- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 249-263 of
582 results
1020 Exhibit: EX1020 Yanagawa
Document
IPR2017-01550, No. 1020-20 Exhibit - EX1020 Yanagawa (P.T.A.B. Jun. 9, 2017)
|
|
Cite Document
1016 Exhibit: EX1016 Virley
Document
IPR2017-01550, No. 1016-16 Exhibit - EX1016 Virley (P.T.A.B. Jun. 9, 2017)
|
|
Cite Document
1016 Exhibit: Ex 1016 Virley, Developing Therapeutics for the Treatment of Multiple...
Document
IPR2017-01929, No. 1016-18 Exhibit - Ex 1016 Virley, Developing Therapeutics for the Treatment of Multiple Sclerosis 2005 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1005 Exhibit: Ex 1005 Thomson, FTY720 in Multiple Sclerosis 2006
Document
IPR2017-01929, No. 1005-4 Exhibit - Ex 1005 Thomson, FTY720 in Multiple Sclerosis 2006 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1036 Exhibit: Ex 1036 FDA approval letter for Tysabri, obtained from the Food and ...
Document
IPR2017-01929, No. 1036-38 Exhibit - Ex 1036 FDA approval letter for Tysabri, obtained from the Food and Drug Administration last accessed January 30, 2017 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1029 Exhibit: Ex 1029 Kataoka, et al, FTY720, Sphingosine 1 Phosphate Receptor...
Document
IPR2017-01929, No. 1029-31 Exhibit - Ex 1029 Kataoka, et al, FTY720, Sphingosine 1 Phosphate Receptor Modulator, Ameliorates Experimental Autoimmune Encephalomyelitis 2005 (P.T.A.B...
|
|
Cite Document
1031 Exhibit: Ex 1031 Kahan, et al, Pharmacodynamics, Pharmacokinetics, and Sa...
Document
IPR2017-01929, No. 1031-33 Exhibit - Ex 1031 Kahan, et al, Pharmacodynamics, Pharmacokinetics, and Safety of Multiple Doses of FTY720 in Stable Renal Transplant Patients 2003 (P.T.A.B....
|
|
Cite Document
1025 Exhibit: Ex 1025 Inglese, Multiple Sclerosis New Insights and Trends 2006
Document
IPR2017-01929, No. 1025-27 Exhibit - Ex 1025 Inglese, Multiple Sclerosis New Insights and Trends 2006 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1039 Exhibit: Ex 1039 LaMontagne, et al, Antagonism of Sphingosine 1 Phosphate...
Document
IPR2017-01929, No. 1039-41 Exhibit - Ex 1039 LaMontagne, et al, Antagonism of Sphingosine 1 Phosphate Receptors by FTY720 Inhibits Angiogenesis, Jan 2006 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1010 Exhibit: Ex 1010 File History US Patent Application No 13149,468 Part 1
Document
IPR2017-01929, No. 1010-9 Exhibit - Ex 1010 File History US Patent Application No 13149,468 Part 1 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1014 Exhibit: Ex 1014 File History of US Patent Application No 11720,205 Part 2
Document
IPR2017-01929, No. 1014-15 Exhibit - Ex 1014 File History of US Patent Application No 11720,205 Part 2 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1002 Exhibit: Ex 1002 Declaration of Dr Barbara S Giesser
Document
IPR2017-01929, No. 1002-44 Exhibit - Ex 1002 Declaration of Dr Barbara S Giesser (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1006 Exhibit: Ex 1006 U S Patent No 6,004,565 Chiba
Document
IPR2017-01929, No. 1006-5 Exhibit - Ex 1006 U S Patent No 6,004,565 Chiba (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
1007 Exhibit: Ex 1007 Kappos, L, et al, FTY720 in Relapsing MS Results of a Doubl...
Document
IPR2017-01929, No. 1007-6 Exhibit - Ex 1007 Kappos, L, et al, FTY720 in Relapsing MS Results of a Double Blind Placebo Controlled Trial with a Novel Oral Immunomodulator, 2005 (P.T.A.B. A...
|
|
Cite Document
1023 Exhibit: Ex 1023 MCALPINES MULTIPLE SCLEROSIS, 4th Edition, Compston...
Document
IPR2017-01929, No. 1023-25 Exhibit - Ex 1023 MCALPINES MULTIPLE SCLEROSIS, 4th Edition, Compston, ed Elsevier, Inc, December 2005 (P.T.A.B. Aug. 16, 2017)
|
|
Cite Document
